Gonzalez; Frank J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gonzalez; Frank J..The latest application filed is for "methods of characterizing adrenocortical tumors".

Company Profile

1.15.12

Gonzalez; Frank J. - Bethesda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods for detecting neoplasia Grant 10,487,363 - Manna , et al. Nov	2019-11-26
Inhibitors of the farnesoid x receptor and uses in medicine Grant 10,233,209 - Gonzalez , et al.	2019-03-19
Methods Of Characterizing Adrenocortical Tumors App 20180188254 - Patel; Dhaval T. ; et al.	2018-07-05
Inhibitors Of The Farnesoid X Receptor And Uses In Medicine App 20170152283 - Gonzalez; Frank J. ; et al.	2017-06-01
Inhibitors of the farnesoid X receptor and uses in medicine Grant 9,540,415 - Gonzalez , et al. January 10, 2	2017-01-10
Inhibitors Of The Farnesoid X Receptor And Uses In Medicine App 20160159851 - Gonzalez; Frank J. ; et al.	2016-06-09
Compositions And Methods For Detecting Neoplasia App 20150344969 - Manna; Soumen K. ; et al.	2015-12-03
Novel Therapeutic Targets In Inflammatory Bowel Disease App 20110055943 - Gonzalez; Frank J. ; et al.	2011-03-03
Agents that bind to and inhibit human cytochrome P450 2C19 Grant 7,682,800 - Gelboin , et al. March 23, 2	2010-03-23
Biomarkers For Detecting Radiation Exposure: Methods And Uses Thereof App 20090318556 - Idle; Jeffrey R. ; et al.	2009-12-24
Methods And Compositions For Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations App 20090280537 - Gonzalez; Frank J. ; et al.	2009-11-12
Antibodies that bind to and inhibit human cytochrome P450 2C91, 2C92, and 2C9*3 Grant 7,524,939 - Gelboin , et al. April 28, 2	2009-04-28
Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations Grant 7,402,387 - Gonzalez , et al. July 22, 2	2008-07-22
Agents that bind to and inhibit human cytochrome P450 2C19 Grant 7,262,018 - Gelboin , et al. August 28, 2	2007-08-28
Agents That Bind To And Inhibit Human Cytochrome P450 2c19 App 20070154971 - Gelboin; Harry V. ; et al.	2007-07-05
Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations App 20050136433 - Gonzalez, Frank J. ; et al.	2005-06-23
Agents that bind to and inhibit human cytochrome P450 2C19 Grant 6,908,738 - Gelboin , et al. June 21, 2	2005-06-21
Agents that bind to and inhibit human cytochrome P450 2C8, 2C9, 2C18 and 2C19 App 20050075487 - Gelboin, Harry V. ; et al.	2005-04-07
Agents that bind to and inhibit human cytochrome P450 2C19 App 20050054009 - Gelboin, Harry V. ; et al.	2005-03-10
Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations Grant 6,787,306 - Gonzalez , et al. September 7, 2	2004-09-07
Agents that bind to and inhibit human cytochrome P450 2C8, 2C9, 2C18 and 2C19 Grant 6,623,960 - Gelboin , et al. September 23, 2	2003-09-23
Agents that bind to and inhibit human cytochrome P450 2C19 App 20020115124 - Gelboin, Harry V. ; et al.	2002-08-22
Inhibitory and non-inhibitory antigen binding polypeptides against human P450 enzymes Grant 5,939,530 - Gelboin , et al. August 17, 1	1999-08-17
Method for detecting a receptor-ligand complex using a cytochrome P450 reporter gene Grant 5,726,041 - Chrespi , et al. March 10, 1	1998-03-10
P450db1 clones for identifying humans with genetic defect in drug metabolism Grant 5,508,199 - Gonzalez , et al. April 16, 1	1996-04-16
Immortalized human cell lines containing exogenous cytochrome P450 genes Grant 5,506,131 - Harris , et al. * April 9, 1	1996-04-09
Immortalized human cell lines containing exogenous cytochrome P450 Grant 5,356,806 - Harris , et al. October 18, 1	1994-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.